MEDCOM USA INC
NT 10-Q, 2000-11-14
TELEPHONE COMMUNICATIONS (NO RADIOTELEPHONE)
Previous: CORRPRO COMPANIES INC /OH/, 10-Q, EX-27, 2000-11-14
Next: SOUND SOURCE INTERACTIVE INC /DE/, 10QSB, 2000-11-14





                     U.S. SECURITIES AND EXCHANGE COMMISSION
                             WASHINGTON, D.C. 20549

                                                       SEC File Number 0-25474
                                                       CUSIP Number 584-062-103

                                   FORM 12b-25

                           NOTIFICATION OF LATE FILING

                                  (Check One):

[ ] Form 10-K  [ ] Form 20-F  [ ] Form 11-K  [X] Form 10-Q  [ ] Form N-SAR

For Period Ended: September 30, 2000
---------------------------------

    Nothing in this Form shall be  construed  to imply that the  Commission  has
verified any information contained herein.
---------------------------------

     If the  notification  relates  to a portion of the  filing  checked  above,
identify the Item(s) to which the notification relates: N/A

---------------------------------
Part I - Registrant Information
---------------------------------

Full Name of Registrant:  Medcom USA Incorporated

Former Name if Applicable:  Sims Communications, Incoporated

Address of Principal Executive Office (Street and Number)

    18001 Cowan, Suites C & D

City, State and Zip Code

    Irvine, California 92614


<PAGE>


---------------------------------
Part II - Rules 12b-25(b) and (c)
---------------------------------

    If the subject  report  could not be filed  without  unreasonable  effort or
expense  and  the  registrant  seeks  relief  pursuant  to Rule  12b-25(b),  the
following should be completed. (Check box if appropriate)

      (a) The reasons  described in  reasonable  detail in Part III of this form
could not be eliminated without unreasonable effort or expense;

[X] (b) The subject annual report,  semi-annual  report, or transition report or
portion thereof will be filed on or before the fifteenth  calendar day following
the prescribed due date; or the subject quarterly report or transition report on
Form l0-Q or portion  thereof will be filed on or before the fifth  calendar day
following the prescribed due date; and

      (c) The accountant's statement or other exhibit required by Rule 12b-25(c)
has been attached if applicable.

---------------------------------
Part III - Narrative
---------------------------------

    State below in reasonable  detail the reasons why the Form 10-K, 20-F, 11-K,
10-Q, or N-SAR,  or the transition  report or portion thereof could not be filed
within the prescribed time period.

      The  Company  did not  receive  information  with  respect to its  foreign
subsidiary to enable it to complete the preparation of its financial  statements
for the quarter ending September 30, 2000 in sufficient time so as to permit the
filing of the 10-QSB report by November 14, 2000.

---------------------------------
Part IV - Other Information
---------------------------------

(1)  Name  and  telephone  number  of  person  to  contact  in  regard  to  this
     notification

     William T. Hart                 (303)                        839-0061
     ---------------                 -----                        --------
         (Name)                   (Area Code)                (Telephone Number)



<PAGE>


    (2) Have all other  periodic  reports  required under Section 13 or 15(d) of
the Securities  Exchange Act of 1934 during the preceding l2 months (or for such
shorter  period that the  registrant  was  required to file such  reports)  been
filed? If answer is no, identify report(s).
                           [X] Yes  [ ] No

     (3) Is it anticipated that any significant  change in results of operations
from the corresponding  period for the last fiscal year will be reflected by the
earnings statements to be included in the subject report or portion thereof?
                           [ ] Yes [X] No

         If  so:  attach  an  explanation  of  the  anticipated   change,   both
narratively and  quantitatively,  and, if  appropriate,  state the reasons why a
reasonable estimate of the results cannot be made.

                            Medcom USA, Incorporated.
                     ----------- --------------------------
                  (Name of Registrant as specified in charter)

has  caused  this  notification  to be signed on its  behalf by the  undersigned
thereunto duly authorized.


Date:  November 14, 2000            By:  /s/ Michael Malet
                                         -------------------------------
                                         Michael Malet, Vice President



                                    ATTENTION

     Intentional  misstatements or omissions of fact constitute Federal Criminal
Violations (See 18 U.S.C. 1001).



© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission